SEP 23, 2021 8:00 AM PDT

Skin Microbiome Analysis Gets Cleaned Up

WRITTEN BY: Tara Fernandez


Our skin is home to a carnival of millions of bacteria, fungi, and viruses that together form the dermal microbiota. These tiny guests that colonize the largest organ of the human body have essential roles in keeping pathogens at bay and breaking down natural waste products.

We also know that this delicate ecosystem of microorganisms is compromised in skin pathologies such as dermatitis and acne. For this reason, efforts to map and study the human skin microbiome have intensified in recent years.

Standing in the way of answers, however, are several technical challenges. For example, growing skin bacteria in a lab setting isn't easy. Conventionally, these bacteria are cultured on agar plates to create colonies that can then be studied. The problem is that not all bacterial species living on skin grow equally under these artificial conditions, with slower-growing species often getting overlooked.

More recently, researchers have turned to advanced sequencing technologies to perform skin microbiome surveys. In this case, contaminating genetic material from skin cells and dead bacteria can muddy the sequence information obtained, making it difficult to get clear answers.

A new study has revealed a way of 'cleaning up' samples to remove contaminating non-target DNA, leaving behind only the genetic material of live bacteria that make up the microbiome. 

Scientists from the Technical University of Munich developed a method of using an enzyme called benzonase for this clean-up step. Benzonase chops up genetic material into tiny fragments. However, the genomes of live bacteria are spared from the enzyme's slicing and dicing because of their protective outer cell walls.

The fragments can then be mechanically separated before performing 16S sequencing, a method for mapping the genetic composition of intact bacteria.

Lead author Martin Köberle said: "The enzyme-based selection of living skin bacteria can help us to find microbial biomarkers for certain dermatological illnesses and also to identify the bacteria that have a positive influence on the course of the disease. Perhaps they will be used in treatments one day." 

 



 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
AUG 05, 2021
Clinical & Molecular DX
Gene Markers in Mothers Point to the Risk of Preterm Birth
AUG 05, 2021
Gene Markers in Mothers Point to the Risk of Preterm Birth
Preterm births—when the baby is born fewer than 37 weeks gestational age—are very common. Experts estimate o ...
AUG 08, 2021
Cardiology
Strong Links Between PTSD and Heart Disease
AUG 08, 2021
Strong Links Between PTSD and Heart Disease
The link between heart disease and stress is well known, but researchers still have a lot to learn about that associatio ...
SEP 30, 2021
Clinical & Molecular DX
How Babies Look at Objects Linked to Future Autism Diagnoses
SEP 30, 2021
How Babies Look at Objects Linked to Future Autism Diagnoses
At nine months old, most babies have started moving around independently and are curiously exploring the exciting new wo ...
OCT 04, 2021
Genetics & Genomics
Zaki syndrome - Pediatric Disorder & Potential Treatment ID'ed
OCT 04, 2021
Zaki syndrome - Pediatric Disorder & Potential Treatment ID'ed
Since it's become quick and relatively inexpensive to sequence a human genome, researchers have gained unprecedented and ...
OCT 07, 2021
Drug Discovery & Development
Extended approval for a drug to treat children living with HIV
OCT 07, 2021
Extended approval for a drug to treat children living with HIV
On Monday October 4th, ViiV Healthcare announced that it had submitted an application to the United States Food and Drug ...
Loading Comments...